Arcellx, Inc.
(ACLX - NASDAQ)
115,11 USD
📋 Profilo Aziendale

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases.

|